Prevalence of diabetes in Australia: insights from the Fremantle Diabetes Study Phase II

Wendy A. Davis, Kirsten E. Peters, Ashley Makepeace, Shaye Griffiths, Christine Bundell, Struan F.A. Grant, Sian Ellard, Andrew T. Hattersley, Stephen A. Paul Chubb, David G. Bruce, Timothy M.E. Davis

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: Accurate diabetes prevalence estimates are important for health service planning and prioritisation. Available data have limitations, suggesting that the contemporary burden of diabetes in Australia is best assessed from multiple sources. Aims: To use systematic active detection of diabetes cases in a postcode-defined urban area through the Fremantle Diabetes Study Phase II (FDS2) to complement other epidemiological and survey data in estimating the national prevalence of diabetes and its types. Methods: People with known diabetes in a population of 157 000 were identified (n = 4639) from a variety of sources and those providing informed consent (n = 1668 or 36%) were recruited to the FDS2 between 2008 and 2011. All FDS2 participants were assigned a type of diabetes based on clinical and laboratory (including serological and genetic) features. Data from people identified through the FDS2 were used to complement Australian Health Survey and National Diabetes Services Scheme prevalence estimates (the proportions of people well controlled on no pharmacotherapy and registering with the National Diabetes Services Scheme respectively) in combination with Australian Bureau of Statistics data to generate the prevalence of diabetes in Australia. Results: Based on data from multiple sources, 4.8% or 1.1 million Australians had diabetes in 2011–2012, of whom 85.8% had type 2 diabetes, 7.9% type 1 diabetes and 6.3% other types (latent autoimmune diabetes of adults, monogenic diabetes and secondary diabetes). Conclusions: Approximately 1 in 20 Australians has diabetes. Although most have type 2 diabetes, one in seven has other types that may require more specialised diagnosis and/or management.

Original languageEnglish
Pages (from-to)803-809
Number of pages7
JournalInternal Medicine Journal
Volume48
Issue number7
DOIs
Publication statusPublished - 1 Jul 2018

Fingerprint

Type 2 Diabetes Mellitus
Health Planning
Information Storage and Retrieval
Health Surveys
Informed Consent
Type 1 Diabetes Mellitus
Health Services
Drug Therapy
Population
Latent Autoimmune Diabetes in Adults
Surveys and Questionnaires

Cite this

Davis, Wendy A. ; Peters, Kirsten E. ; Makepeace, Ashley ; Griffiths, Shaye ; Bundell, Christine ; Grant, Struan F.A. ; Ellard, Sian ; Hattersley, Andrew T. ; Paul Chubb, Stephen A. ; Bruce, David G. ; Davis, Timothy M.E. / Prevalence of diabetes in Australia : insights from the Fremantle Diabetes Study Phase II. In: Internal Medicine Journal. 2018 ; Vol. 48, No. 7. pp. 803-809.
@article{8622c8cbbdfb45279df50b0932ce476d,
title = "Prevalence of diabetes in Australia: insights from the Fremantle Diabetes Study Phase II",
abstract = "Background: Accurate diabetes prevalence estimates are important for health service planning and prioritisation. Available data have limitations, suggesting that the contemporary burden of diabetes in Australia is best assessed from multiple sources. Aims: To use systematic active detection of diabetes cases in a postcode-defined urban area through the Fremantle Diabetes Study Phase II (FDS2) to complement other epidemiological and survey data in estimating the national prevalence of diabetes and its types. Methods: People with known diabetes in a population of 157 000 were identified (n = 4639) from a variety of sources and those providing informed consent (n = 1668 or 36{\%}) were recruited to the FDS2 between 2008 and 2011. All FDS2 participants were assigned a type of diabetes based on clinical and laboratory (including serological and genetic) features. Data from people identified through the FDS2 were used to complement Australian Health Survey and National Diabetes Services Scheme prevalence estimates (the proportions of people well controlled on no pharmacotherapy and registering with the National Diabetes Services Scheme respectively) in combination with Australian Bureau of Statistics data to generate the prevalence of diabetes in Australia. Results: Based on data from multiple sources, 4.8{\%} or 1.1 million Australians had diabetes in 2011–2012, of whom 85.8{\%} had type 2 diabetes, 7.9{\%} type 1 diabetes and 6.3{\%} other types (latent autoimmune diabetes of adults, monogenic diabetes and secondary diabetes). Conclusions: Approximately 1 in 20 Australians has diabetes. Although most have type 2 diabetes, one in seven has other types that may require more specialised diagnosis and/or management.",
keywords = "Australia, diabetes, diabetes type, prevalence",
author = "Davis, {Wendy A.} and Peters, {Kirsten E.} and Ashley Makepeace and Shaye Griffiths and Christine Bundell and Grant, {Struan F.A.} and Sian Ellard and Hattersley, {Andrew T.} and {Paul Chubb}, {Stephen A.} and Bruce, {David G.} and Davis, {Timothy M.E.}",
year = "2018",
month = "7",
day = "1",
doi = "10.1111/imj.13792",
language = "English",
volume = "48",
pages = "803--809",
journal = "Internal Medicine Journal (Print)",
issn = "1444-0903",
publisher = "John Wiley & Sons",
number = "7",

}

Davis, WA, Peters, KE, Makepeace, A, Griffiths, S, Bundell, C, Grant, SFA, Ellard, S, Hattersley, AT, Paul Chubb, SA, Bruce, DG & Davis, TME 2018, 'Prevalence of diabetes in Australia: insights from the Fremantle Diabetes Study Phase II' Internal Medicine Journal, vol. 48, no. 7, pp. 803-809. https://doi.org/10.1111/imj.13792

Prevalence of diabetes in Australia : insights from the Fremantle Diabetes Study Phase II. / Davis, Wendy A.; Peters, Kirsten E.; Makepeace, Ashley; Griffiths, Shaye; Bundell, Christine; Grant, Struan F.A.; Ellard, Sian; Hattersley, Andrew T.; Paul Chubb, Stephen A.; Bruce, David G.; Davis, Timothy M.E.

In: Internal Medicine Journal, Vol. 48, No. 7, 01.07.2018, p. 803-809.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Prevalence of diabetes in Australia

T2 - insights from the Fremantle Diabetes Study Phase II

AU - Davis, Wendy A.

AU - Peters, Kirsten E.

AU - Makepeace, Ashley

AU - Griffiths, Shaye

AU - Bundell, Christine

AU - Grant, Struan F.A.

AU - Ellard, Sian

AU - Hattersley, Andrew T.

AU - Paul Chubb, Stephen A.

AU - Bruce, David G.

AU - Davis, Timothy M.E.

PY - 2018/7/1

Y1 - 2018/7/1

N2 - Background: Accurate diabetes prevalence estimates are important for health service planning and prioritisation. Available data have limitations, suggesting that the contemporary burden of diabetes in Australia is best assessed from multiple sources. Aims: To use systematic active detection of diabetes cases in a postcode-defined urban area through the Fremantle Diabetes Study Phase II (FDS2) to complement other epidemiological and survey data in estimating the national prevalence of diabetes and its types. Methods: People with known diabetes in a population of 157 000 were identified (n = 4639) from a variety of sources and those providing informed consent (n = 1668 or 36%) were recruited to the FDS2 between 2008 and 2011. All FDS2 participants were assigned a type of diabetes based on clinical and laboratory (including serological and genetic) features. Data from people identified through the FDS2 were used to complement Australian Health Survey and National Diabetes Services Scheme prevalence estimates (the proportions of people well controlled on no pharmacotherapy and registering with the National Diabetes Services Scheme respectively) in combination with Australian Bureau of Statistics data to generate the prevalence of diabetes in Australia. Results: Based on data from multiple sources, 4.8% or 1.1 million Australians had diabetes in 2011–2012, of whom 85.8% had type 2 diabetes, 7.9% type 1 diabetes and 6.3% other types (latent autoimmune diabetes of adults, monogenic diabetes and secondary diabetes). Conclusions: Approximately 1 in 20 Australians has diabetes. Although most have type 2 diabetes, one in seven has other types that may require more specialised diagnosis and/or management.

AB - Background: Accurate diabetes prevalence estimates are important for health service planning and prioritisation. Available data have limitations, suggesting that the contemporary burden of diabetes in Australia is best assessed from multiple sources. Aims: To use systematic active detection of diabetes cases in a postcode-defined urban area through the Fremantle Diabetes Study Phase II (FDS2) to complement other epidemiological and survey data in estimating the national prevalence of diabetes and its types. Methods: People with known diabetes in a population of 157 000 were identified (n = 4639) from a variety of sources and those providing informed consent (n = 1668 or 36%) were recruited to the FDS2 between 2008 and 2011. All FDS2 participants were assigned a type of diabetes based on clinical and laboratory (including serological and genetic) features. Data from people identified through the FDS2 were used to complement Australian Health Survey and National Diabetes Services Scheme prevalence estimates (the proportions of people well controlled on no pharmacotherapy and registering with the National Diabetes Services Scheme respectively) in combination with Australian Bureau of Statistics data to generate the prevalence of diabetes in Australia. Results: Based on data from multiple sources, 4.8% or 1.1 million Australians had diabetes in 2011–2012, of whom 85.8% had type 2 diabetes, 7.9% type 1 diabetes and 6.3% other types (latent autoimmune diabetes of adults, monogenic diabetes and secondary diabetes). Conclusions: Approximately 1 in 20 Australians has diabetes. Although most have type 2 diabetes, one in seven has other types that may require more specialised diagnosis and/or management.

KW - Australia

KW - diabetes

KW - diabetes type

KW - prevalence

UR - http://www.scopus.com/inward/record.url?scp=85049583881&partnerID=8YFLogxK

U2 - 10.1111/imj.13792

DO - 10.1111/imj.13792

M3 - Article

VL - 48

SP - 803

EP - 809

JO - Internal Medicine Journal (Print)

JF - Internal Medicine Journal (Print)

SN - 1444-0903

IS - 7

ER -